Gastrointestinal manifestations of long COVID
Louise R. King
Abstract
Long COVID is estimated to have affected 6.9 % of US adults, 17.8 million people in the US alone, as of early 2023. While SARS-CoV-2 is primarily considered a respiratory virus, gastrointestinal (GI) symptoms are also...
Multi-method phenotyping of Long COVID patients using high-dimensional symptom data
Background
Long COVID, characterized by symptoms that remain or emerge in the months after infection with COVID-19, has complex and highly variable patient presentations, with myriad seemingly disconnected...
A call from patient-researchers to advance research on long COVID
Abstract
Long COVID is a chronic and often disabling illness with long-term consequences. Although progress has been made in the clinical characterization of long COVID, no approved treatments exist and disconnects between...
Objectives
Long COVID-19 (LC) patients experience a number of chronic idiopathic symptoms that are highly similar to those of post-viral Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). We have therefore performed a systematic review and meta-analysis to determine the proportion of...
Crowd-sourced machine learning prediction of long COVID using data from the National COVID Cohort Collaborative
Timothy Bergquist, Johanna Loomba, Emily Pfaff, Fangfang Xia, Zixuan Zhao, Yitan Zhu
Background
While many patients seem to recover from SARS-CoV-2 infections, many patients report...
Summary
Long COVID, a type of post-acute sequelae of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (PASC) defined by medically unexplained symptoms following infection with SARS-CoV-2, is a newly recognized infection-associated chronic condition that causes disability in some...
Abstract
The main objective was to evaluate structural and functional connectivity correlates of fatigue in post-COVID syndrome, and to investigate the relationships with an objective measure of mental fatigue and with subjective cognitive complaints. One-hundred and twenty-nine patients were...
The group will work to develop guidance about Long Covid and how psychologists contribute to rehabilitation, treatment and support.
Dr Faith Martin, one of the group leads, said:
"Around 2 million adults are known to be living with Long Covid in the UK. It is vital that we work with experts...
Introduction: There is a growing interest in the effect of Long-COVID (LC) on cognition, and neuroimaging allows us to gain insight into the structural and functional changes underlying cognitive impairment in LC. We used multimodal neuroimaging data in combination with neuropsychological...
Now published: link here
Preprint
Background: Post COVID-19 syndrome or Long Covid (LC) is a novel fluctuating condition with a protracted course in some patients. Specialist LC services have been operational in the UK since 2020 and deal with a high caseload of patients. Aims: To evaluate...
Antecedent and persistent symptoms in COVID-19 and other respiratory illnesses: insights from prospectively collected data in the BRACE trial
Background
Some individuals have a persistence of symptoms following both COVID-19 (post-acute COVID-19 syndrome; PACS) and other viral infections. This...
Now published: link here
Preprint
Background. The Stroop task was used to investigate differences in cognitive function between Long COVID (LC), Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME/CFS) and healthy control subjects.
Methods. Subjects viewed four color words or neutral...
The German late night talk show ZDF Magazin Royal hosted by Jan Böhmermann did a full episode on long COVID and ME/CFS.
Some quotes from an AI translation:
So in the Jon vs John race to cover ME on their show, amazingly the winner is Jan.
Boglárka Nagy
Andrea B. Protzner,
Balázs Czigler &
Zsófia Anna Gaál
Abstract
Post-COVID syndrome manifests with numerous neurological and cognitive symptoms, the precise origins of which are still not fully understood. As females and older adults are more susceptible to developing this...
Abstract
Background
Few longitudinal studies available characterize long COVID outcomes out to 24 months, especially in people with nonsevere acute coronavirus disease 2019 (COVID-19). This study sought to prospectively characterize incidence and duration of long COVID symptoms and their...
Abstract
Objectives: We aimed to identify trajectories of the evolution of post-COVID-19 condition, up to 2 years after symptom onset.
Methods: The ComPaRe long COVID e-cohort is a prospective cohort of patients with symptoms lasting at least 2 months after SARS-CoV2 infection. We used...
Abstract
While the acute manifestations of infectious diseases are well known, in some individuals, symptoms can either persist or appear after the acute period. Post-viral fatigue syndromes are recognized with other viral infections and are described after COVID-19. We have a growing number of...
Highlights
• Persistent symptoms were greater following the first SARS-CoV-2 infection.
• The most frequent persistent symptoms were fatigue, tiredness and shortness of breath.
• Proportion of persistent symptoms varied by variant of infection.
• A reduction of persistent symptoms after COVID-19...
Abstract
Postural orthostatic tachycardia syndrome (POTS) occurs in approximately 30% of people with highly symptomatic post-COVID-19 condition (PCC). It involves several symptoms that limit physical and psychological functions and cause reduced quality of life.
Evidence for different...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.